Elsevier

Biomaterials

Volume 10, Issue 3, April 1989, Pages 147-155
Biomaterials

Paper
Effect of albumin coating on the in vitro blood compatibility of Dacron® arterial prostheses

https://doi.org/10.1016/0142-9612(89)90017-3Get rights and content

Abstract

A recirculating in vitro perfusion system was used to assess the effect of albumin precoating on the thrombogenicity of Dacron® vascular grafts. A complete analysis of platelet activation was carried out, involving platelet count, release, adhesion and aggregation. Fibrin formation was assessed by measuring fibrinogen levels and fibrinopeptide A production; leucocyte interaction was analysed by measuring total leucocyte count as well as an analysis of cell adhesion to the surface by scanning electron microscopy. The platelet count decreased progressively with perfusion time for Dacron® until by 30 min, it had declined to 69% ± 2% of baseline. The platelet count did not, however, change significantly from baseline when albumin-coated Dacron® was tested. Release of platelet factor 4 and β-thromboglobulin at 180 min for Dacron® was 37.8 ± 29.8 times and 66.9 ± 18.2 times baseline, respectively, while albumin coating caused significantly less (P < 0.03) platelet release. Albumin coating diminished coagulation activation and fibrinopeptide A formation. The total leucocyte concentration decreased significantly for Dacron® by 180 min, while that for albumin-coated Dacron® did not change significantly from baseline levels. Albumin coating produced a film-like covering over the Dacron®. For Dacron®, there were numerous leucocytes and platelets adherent to the surface, whilst cellular deposition was minimal upon the albumin-coated surface. Thus, albumin coating improved the short-term blood compatibility of Dacron® by all of the methods employed in this study.

References (39)

  • J.V Bascom

    Gelatin sealing to prevent blood loss from knitted arterial grafts

    Surgery

    (1961)
  • A.W Humphries et al.

    Arterial prostheses of collagen impregnated Dacron tubes

    Surgery

    (1961)
  • G.A Adams et al.

    Kinetics of platelet adhesion and aggregation on protein-coated surfaces: morphology and release from dense granules

    ASAIO J.

    (1981)
  • M.A Packham et al.

    The effect of plasma proteins on the interaction of platelets with glass surfaces

    J. Lab. Clin. Med.

    (1969)
  • D.J Lyman et al.

    Platelet interaction with protein coated surfaces

    Thromb. Diath. Haemor. Proc. Suppl.

    (1970)
  • T.M.S Chang

    Platelet-surface interaction: effect of albumin coating or heparin complexing on thrombogenic surfaces

    Can. J. Physiol. Pharmacol.

    (1974)
  • R.G Guidoin et al.

    Blood compatibility of silicons rubber chemically coated with cross-linked albumin, Biomat

    Med. Dev. Artif. Org.

    (1976)
  • R.G Guidoin et al.

    Albumin coated and critical point dried polyester prostheses as substitutes in the thoracic aorta of dogs

    Trans. Am. Soc. Artif. Intern. Organs

    (1983)
  • D Domurado et al.

    Albuminated Dacron prostheses as improved blood vessel Substitutes

    J. Bioeng.

    (1978)
  • Cited by (207)

    • Profiling of time-dependent human plasma protein adsorption on non-coated and heparin-coated oxygenator membranes

      2022, Biomaterials Advances
      Citation Excerpt :

      This displacement effect could potentially be prolonged by a combination coating of albumin and heparin-ATIII complexes. Albumin coating has been used previously to improve the biocompatibility of vascular grafts, resulting in less cell deposition [63]. The commercially used Bioline® coating consists of a recombinant human albumin layer with covalently bound heparin [64].

    • Nonthrombogenic Treatments and Strategies

      2020, Biomaterials Science: An Introduction to Materials in Medicine
    View all citing articles on Scopus

    Current address: Division of Laboratory Medicine, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44106, USA.

    View full text